Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Navigating volatility

The TSX and the TSX Venture Exchange have faced significant turbulence this week after a major global sell-off, an unexpected development given the TSX’s recent all-time high. This stark contrast points to the current market volatility, reminding investors...

Buzz on the Bullboards: Cyanide, Bombardier and healthcare AI

Investors seem to be keeping their money at home this summer, given how the markets have performed in Toronto and New York. In New York, the Nasdaq and the S&P 500 reached new trading highs on more than one occasion in the past few days alone. This was driven by stron...

Buzz on the Bullboards: Who benefits from the latest stock market rally?

It was a more nuanced performance for stock markets in Toronto and New York this week with notable gains and splits between indices capturing investor attention. The TSX surged to highs not seen in a month, buoyed by optimism, while in the United States, some stocks ...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

Buzz on the Bullboards: Recognizing the best of the best

Investors don’t prosper on potential. Investors prosper on returns. These days, plenty of companies are able to reward return-starved investors with a strong stock performance. However, many still look to short-term trading or chasing momentum for a qu...

Buzz on the Bullboards: Who’s filling the void in the tech selloff?

Last week was full of tough questions for investors navigating the waters of a sea of global economic uncertainty and confusion. Investors remain in a holding pattern as we witnessed some of the most popular companies among our communities (many in the tech sector) st...

Buzz on the Bullboards: Good stocks with bad publicity

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” Many stock markets may have seen a higher start to the year so far, but there is far from a universal sentiment across the sectors, with s...

Pharmaceutical company treats bladder cancer with new tech

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Theralase Technologies Inc. (TSXV:TLT) , a clinical-stage pharmaceutical company, is currently developing an innovative, research-backed technology for the ...

Xcyte Digital goes public with one-stop immersive event technology

Xcyte Digital Corp. (TSXV:XCYT) has accrued more than 150,000 events with more than 100 million participants through its acquired business assets. The company provides immersive technology solutions – which include virtual, augmented and extended reality for compan...

Fineqia International brings investors lucrative, risk-mitigated opportunities

Fineqia International Inc. (CSE:FNQ) is a digital asset business. It makes investments from its own balance sheet, targeting early stage companies; businesses in blockchain, fintech, artificial intelligence and NFTs. Its platform also helps to brings crowd investors luc...
1 2 3 4 5 6 7 8 9 10 ...